Literature DB >> 7073345

Cartilage specific collagen activates macrophages and the alternative pathway of complement: evidence for an immunopathogenic concept of rheumatoid arthritis.

H M Hanauske-Abel, B F Pontz, H U Schorlemmer.   

Abstract

We studied the effect of human interstitial collagen types I, II, and III on serum-free cultured mouse macrophages and on the complement classical and alternative pathways in human and guinea-pig serum. Type II collagen produced a dose-dependent consumption and conversion of C3 and factor B both in the homologous and in the heterologous system. This effect on the alternative pathway was reproduced in genetically C4-deficient guinea-pig serum and could be triggered by native, triple helical type II molecules, by their component alpha chains, and the CNBr peptide mixture. Addition of type II collagen to the mouse macrophage cultures induced not only a dose- and time-dependent secretion of lysosomal enzymes, but also the generation of a supernatant factor cytotoxic for mouse mastocytoma P 815 cells. Collagen of types I and III were conspicuously less active or inactive in all assays. The studies demonstrate properties of the collagen specific for cartilage which, on a molecular level, suggest its direct, local participation in the production and perpetuation of rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7073345      PMCID: PMC1000903          DOI: 10.1136/ard.41.2.168

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  31 in total

1.  Interaction of collagen with serum complement: inhibition of complement-mediated hemolysis.

Authors:  M Takahashi; S KawachiTakahashi; M Matsuura
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

2.  (Alpha1(3))3 human skin collagen. Release by pepsin digestion and preponderance in fetal life.

Authors:  E H Epstein
Journal:  J Biol Chem       Date:  1974-05-25       Impact factor: 5.157

3.  Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsin.

Authors:  E J Miller
Journal:  Biochemistry       Date:  1972-12-19       Impact factor: 3.162

4.  Characterization of collagen peptides by sodium dodecylsulfate-polyacrylamide electrophoresis.

Authors:  H Furthmayr; R Timpl
Journal:  Anal Biochem       Date:  1971-06       Impact factor: 3.365

5.  Isolation and characterization of a collagen from chick cartilage containing three identical alpha chains.

Authors:  E J Miller
Journal:  Biochemistry       Date:  1971-04-27       Impact factor: 3.162

6.  Association of experimental chronic arthritis with the persistence of group A streptococcal cell walls in the articular tissue.

Authors:  J H Schwab; W J Cromartie; S H Ohanian; J G Craddock
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

7.  Proteinase inhibitors in human synovial fluid.

Authors:  G Shtacher; R Maayan; G Feinstein
Journal:  Biochim Biophys Acta       Date:  1973-03-23

8.  Rheumatoid synovitis. An extravascular immune complex disease.

Authors:  N J Zvaifler
Journal:  Arthritis Rheum       Date:  1974 May-Jun

9.  Independent and consecutive action of the complement components C5, C6 and C7 in immune hemolysis. I. Preparation of EAC1-5 with purified guinea pig C3 and C5.

Authors:  D Bitter-Suermann; U Hadding; F Melchert; H J Wellensiek
Journal:  Immunochemistry       Date:  1970-12

10.  Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritis.

Authors:  S Ruddy; D T Fearon; K F Austen
Journal:  Arthritis Rheum       Date:  1975 Jul-Aug
View more
  9 in total

Review 1.  Complement in the immunopathogenesis of rheumatic disease.

Authors:  Gunnar Sturfelt; Lennart Truedsson
Journal:  Nat Rev Rheumatol       Date:  2012-06-05       Impact factor: 20.543

2.  Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA).

Authors:  M A Friese; J Hellwage; T S Jokiranta; S Meri; H J Müller-Quernheim; H H Peter; H Eibel; P F Zipfel
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

3.  Pyridinedicarboxylates, the first mechanism-derived inhibitors for prolyl 4-hydroxylase, selectively suppress cellular hydroxyprolyl biosynthesis. Decrease in interstitial collagen and Clq secretion in cell culture.

Authors:  G Tschank; M Raghunath; V Günzler; H M Hanauske-Abel
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

Review 4.  Etiology of rheumatoid arthritis.

Authors:  T Kouri
Journal:  Experientia       Date:  1985-04-15

5.  Bidirectional erosion of cartilage in the rheumatoid knee joint.

Authors:  M Bromley; H Bertfield; J M Evanson; D E Woolley
Journal:  Ann Rheum Dis       Date:  1985-10       Impact factor: 19.103

6.  Release of endogenous anti-inflammatory complement regulators FHL-1 and factor H protects synovial fibroblasts during rheumatoid arthritis.

Authors:  M A Friese; T Manuelian; S Junnikkala; J Hellwage; S Meri; H H Peter; D L Gordon; H Eibel; P F Zipfel
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

7.  Return to sports activity in the revision of anterior cruciate ligament reconstruction: A 2-6 Year follow-up study.

Authors:  Mohsen Mardani-Kivi; Ehsan Kazemnejad Leili; Ardeshir Shirangi; Zoleikha Azari
Journal:  J Clin Orthop Trauma       Date:  2020-12-26

8.  The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis.

Authors:  André Struglics; Marcin Okroj; Per Swärd; Richard Frobell; Tore Saxne; L Stefan Lohmander; Anna M Blom
Journal:  Arthritis Res Ther       Date:  2016-10-06       Impact factor: 5.156

9.  The application of optical coherence tomography in musculoskeletal disease.

Authors:  Christopher Rashidifard; Christopher Vercollone; Scott Martin; Bin Liu; Mark E Brezinski
Journal:  Arthritis       Date:  2013-01-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.